Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
Electropysiologic evaluation of the visual pathway in patients with multiple sclerosis.
Th17 Pathway As a Target for Multipotent Stromal Cell Therapy in Dogs: Implications for Translational Research.
Proof-of Concept that an Acute Trophic Factors Intervention After Spinal Cord Injury Provides an Adequate Niche for Neuroprotection, Recruitment of Nestin-Expressing Progenitors and Regeneration.
Acute transverse myelitis in a child with lyme disease and a review of literature.
An update of teriflunomide for treatment of multiple sclerosis.
Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Repeat infusion of autologous bone marrow cells in multiple sclerosis: protocol for a phase I extension study (SIAMMS-II).
Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.
Brain magnetic resonance imaging helps to differentiate atypical multiple sclerosis with cavitary lesions and vanishing white matter disease.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
Extracellular Membrane Vesicles as Vehicles for Brain Cell-to-Cell Interactions in Physiological as well as Pathological Conditions.
Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System.
Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects.
[Proportion and significance of CD1d(hi)CD5(+)CD19(+) regulatory B cell in peripheral blood of patients with neuromyelitis optica].
Quantitative analysis of cerebrospinal fluid brain derived neurotrophic factor in the patients with multiple sclerosis.
IgM to S-nitrosylated protein is found intrathecally in relapsing-remitting multiple sclerosis.
Resource utilization, costs and treatment patterns of switching and discontinuing treatment of MS patients with high relapse activity.
The development of hematopoietic and mesenchymal stem cell transplantation as an effective treatment for multiple sclerosis.
An acute transverse myelitis attack after total body irradiation: a rare case.
Inhibition of phosphoinositide 3-kinase delta attenuates experimental autoimmune encephalomyelitis in mice.
Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage.
Aerobic and resistance exercise improve walking speed and endurance in people with multiple sclerosis [synopsis].
Age-dependent redistribution and hypersialylation of the central myelin paranodal loop membrane protein Opalin in the mouse brain.
An overview of pregnancy-related issues in patients with multiple sclerosis.
Pages
« first
‹ previous
…
655
656
657
658
659
660
661
662
663
…
next ›
last »